BIA welcomes launch of Life Sciences Innovative Manufacturing Fund
The Government has launched the Life Sciences Innovative Manufacturing Fund (LSIMF) a £60 million capital grants scheme which will support life sciences manufacturing.
Steve Bates OBE, Chief Executive of the BioIndustry Association said: “The UK medicine manufacturing community is buoyant after playing a crucial role in manufacturing and scaling up COVID-19 vaccines coupled with significant private sector investment over the past few years. Anchoring and growing this high-value manufacturing industry in the UK is crucial to the UK’s resilience to future health threats as well as the creation of new jobs across the country.
“Today’s announcement by government has been called for by the BIA and our industry partners to strengthen our manufacturing capacity. Key to the success of this fund will be it working for companies of all sizes, from big pharma to SMEs, supporting domestic growth as well as attracting businesses from overseas to invest and manufacture their products here in the UK.”
